Nothing Special   »   [go: up one dir, main page]

Small et al., 2010 - Google Patents

Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction

Small et al., 2010

View PDF @Full View
Document ID
15912038418938998354
Author
Small E
Thatcher J
Sutherland L
Kinoshita H
Gerard R
Richardson J
DiMaio J
Sadek H
Kuwahara K
Olson E
Publication year
Publication venue
Circulation research

External Links

Snippet

Rationale: Myocardial infarction (MI) results in loss of cardiac myocytes in the ischemic zone of the heart, followed by fibrosis and scar formation, which diminish cardiac contractility and impede angiogenesis and repair. Myofibroblasts, a specialized cell type that switches from a …
Continue reading at www.ahajournals.org (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Similar Documents

Publication Publication Date Title
Small et al. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction
Luo et al. Cooperative binding of ETS2 and NFAT links Erk1/2 and calcineurin signaling in the pathogenesis of cardiac hypertrophy
Woodall et al. Cardiac fibroblast GRK2 deletion enhances contractility and remodeling following ischemia/reperfusion injury
He et al. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor–specific Arkadia-mediated downregulation of Smad7
Methawasin et al. Experimentally increasing the compliance of titin through RNA binding motif-20 (RBM20) inhibition improves diastolic function in a mouse model of heart failure with preserved ejection fraction
Seneviratne et al. Interferon regulatory factor 5 controls necrotic core formation in atherosclerotic lesions by impairing efferocytosis
Zhao et al. NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways
Mao et al. Nidogen-2 maintains the contractile phenotype of vascular smooth muscle cells and prevents neointima formation via bridging Jagged1-Notch3 signaling
Rodríguez-Vita et al. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-β–independent mechanism
Gonzalez-Quesada et al. Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation
Abdel-Malak et al. Early growth response-1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation
Van Aelst et al. Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening
Auguste et al. Suppression of activated FOXO transcription factors in the heart prolongs survival in a mouse model of laminopathies
Ding et al. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction
Lähteenvuo et al. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1–and neuropilin receptor-1–dependent mechanisms
Li et al. SIRT1 acts as a modulator of neointima formation following vascular injury in mice
Wang et al. Cartilage oligomeric matrix protein maintains the contractile phenotype of vascular smooth muscle cells by interacting with α7β1 integrin
Widyantoro et al. Endothelial cell–derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition
Huang et al. Smad3 mediates cardiac inflammation and fibrosis in angiotensin II–induced hypertensive cardiac remodeling
Miyamoto et al. Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo
Kim et al. p53 impairs endothelium-dependent vasomotor function through transcriptional upregulation of p66shc
Yang et al. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells
Tucka et al. Akt1 regulates vascular smooth muscle cell apoptosis through FoxO3a and Apaf1 and protects against arterial remodeling and atherosclerosis
Paik et al. Wnt10b gain-of-function improves cardiac repair by arteriole formation and attenuation of fibrosis
Huff et al. Apolipoprotein C-III: going back to the future for a lipid drug target